Peer-influenced content. Sources you trust. No registration required. This is HCN.

Medical News Today (MNT)FDA Reports Raise Concerns About Energy Drinks and Heart Problems in Young Adults

ℹ️ Observational Association Only Evidence

Medical News Today describes an analysis of 28,345 voluntary FDA adverse-event reports from 2017–2025, including 854 involving stimulant-containing energy drinks or supplements. Comparators included 27,491 reports involving products without caffeine or other stimulants. Cardiovascular events appeared more frequently in stimulant-product reports. Presented at AHA Scientific Sessions 2026, the findings were preliminary and not yet peer-reviewed. The database cannot establish causation or event frequency among consumers.


Patient Counseling Points

  • Reporting comparisons: Stimulant-product reports were about 11 times more likely to mention cardiac arrest and 4.5 times more likely to mention heart attack.
  • Other reported events: Ventricular arrhythmias or palpitations, elevated heart rate, chest pain, and fainting also appeared more frequently.
  • Age distribution: Adults ages 18–34 accounted for approximately 45% of stimulant-product cardiovascular reports; this does not establish greater risk than other ages.
  • Unknown absolute risk: The analysis lacked the number of exposed consumers, including those without adverse effects, so it could not calculate event incidence.
  • Unresolved contributors: The analysis could not account for underlying conditions, other substances, exercise, or caffeine amounts, or identify responsible ingredients and combinations.

Patient Care Applications

  • Exposure history: The article suggests asking younger patients with palpitations, chest pain, or fainting about energy drinks and stimulant supplements.
  • Intake awareness: The article discusses checking labels and counting caffeine across beverages and supplements; the analysis did not establish a safe dose.
  • Clinical evaluation: The article advises medical evaluation for chest pain, fainting, or rapid or irregular heartbeat.
  • Pediatric boundary: The reported age finding concerns adults ages 18–34; the article provides no separate cardiovascular results for children or adolescents.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form